Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053037/0738 | |
| Pages: | 10 |
| | Recorded: | 06/25/2020 | | |
| Attorney Dkt #: | 1441-20000.00 // 20000.40 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/05/2021
|
Application #:
|
16849889
|
Filing Dt:
|
04/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/22/2020
| | | | |
|
Title:
|
FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
|
|
|
Assignee
|
|
|
|
|
| 258 DENSLOW AVENUE |
| LOS ANGELES, CALIFORNIA 90049 |
|
|
Correspondence name and address
|
| |
SHANE M. POPP
|
| |
3460 BARRY AVENUE
|
| |
ATTN: QWIXEL THERAPEUTICS
|
| |
LOS ANGELES, CA 90066-2002
|
Search Results as of:
05/12/2024 07:00 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
